Stay updated on IO102/IO103 Combo + Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the IO102/IO103 Combo + Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the IO102/IO103 Combo + Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The revision history now shows a new revision entry (v3.6.2). This update reflects an update to the page's versioning record rather than substantive content changes.
    Difference
    0.1%
    Check dated 2026-06-27T05:59:35.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    A new References section has been added to the study record page, listing sources cited in the record to support the information presented.
    Difference
    0.1%
    Check dated 2026-06-20T06:20:56.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A new revision v3.6.0 was added and the study now shows no longer looking for participants, replacing the previous revision v3.5.5.
    Difference
    0.3%
    Check dated 2026-06-13T05:21:12.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The history now shows a new revision label, v3.5.5, replacing the previous v3.5.4, indicating an update to the study record.
    Difference
    0.1%
    Check dated 2026-06-05T22:14:48.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    A new revision entry 'Revision: v3.5.4' has been added to the history, replacing the previous revision tag. This documents the latest update to the study record's revision metadata.
    Difference
    0.1%
    Check dated 2026-05-15T16:23:05.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    The page’s UI revision indicator was updated from v3.5.2 to v3.5.3, reflecting a software/version change for the ClinicalTrials.gov record history display.
    Difference
    0.1%
    Check dated 2026-04-24T06:14:46.000Z thumbnail image

Stay in the know with updates to IO102/IO103 Combo + Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the IO102/IO103 Combo + Pembrolizumab in Melanoma Clinical Trial page.